Why is Aurobindo Pharma falling/rising?

As of 25-Sep, Aurobindo Pharma Ltd. is experiencing a slight increase in its stock price, currently at 1,095.00, reflecting a change of 3.5 (0.32%) upward. The stock has shown a trend reversal, gaining after four consecutive days of decline. It has outperformed its sector by 1.18% today, with a notable increase in delivery volume, which rose by 5.55% compared to the five-day average. Despite a one-year return of -28.27%, the company maintains a low debt-to-equity ratio and an attractive valuation with a price-to-book value of 2, indicating that it is trading at fair value relative to its peers. High institutional holdings at 41.31% suggest that knowledgeable investors are backing the stock, although profits have decreased by 6.1% over the past year.
In the broader market context, Aurobindo Pharma's short-term performance over the past week has been negative, with a decline of 2.97%, compared to a smaller decline of 2.23% in the Sensex. However, over the past month, the stock has outperformed the benchmark, gaining 2.70% while the Sensex fell by 0.58%. This indicates that while the stock has faced challenges in the longer term, recent movements suggest a potential recovery, supported by increased investor participation and a solid institutional backing.